TG Therapeutics, Inc. (0VGI.L) LSE

37.11

-0.389(-1.04%)

Updated at October 01 04:33PM

Currency In USD

Valuation

Market Cap4.37B
Enterprise Value4.45B
P/E Ratio75.41
PEG Ratio1.45
Price/Sales Ratio10.86
Price/Book Ratio16.49
Enterprise/Revenue11.14
Enterprise/EBITDA52.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.19

Management Effectiveness

Return On Assets0.09
Return On Equity0.26

Income Statement

Revenue329M
Revenue/Share3.09
Gross Profit290.52M
EBITDA49.9M
Net Income23.38M
Diluted EPS0.15

Balance Sheet

Total Cash251.87M
Total Cash/Share1.72
Total Debt253.72M
Total Debt/Equity0.92
Current Ratio3.86
Book Value Per Share1.88

Price History

52-Week Change50.86
52-Week High37.11
52-Week Low6.47
Moving Average 50 Days16.04
Moving Average 200 Days15.15

Statistics

Average Volume12,871
Shares Outstanding146.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A